Latest Breaking News On - International reconstructive - Page 1 : vimarsana.com

Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansionReported first-quarter net loss from continuing operations of $1.32 per share with adjusted.

United statesMatt trerotolaKyle roseEuropean union medical device regulationEuropean unionYork stock exchangeNew york stock exchangeExchange commissionInternational reconstructiveEnovis corporationChief executive officerLima trabecular titanium conesAmerican academyOrthopaedic surgeons annual meetingSecurities litigation reform actAnnual report